7.08.2020

ClinicalTrials.gov has published clinical trials of Bioven.

ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine (NLM) at the National Institutes of Health, and is the largest clinical trials database, holding registrations from over 329,000 trials from 209 countries.

The study, that published on the resource, discusses the Efficacy of Bioven in the High Immunomodulatory Dose in Complex Treatment of Severe Pneumonia Caused by COVID-19 / SARS-CoV-2. During clinical trials, Ukrainian and international experts noted that Bioven reduces the severity of cytokine storms and stabilizes the condition of critically ill patients. All those who took Bioven, observed stabilization of the general condition within 2 days after administration of the drug with a subsequent reduction in the manifestations of respiratory failure.

Share in social networks

To news